International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 2 , Pages 467-476 , 1 February 2010

Impact Factors for Microinvasion in Patients With Hepatocellular Carcinoma: Possible Application to the Definition of Clinical Tumor Volume

  • Min-Hua Wang, M.D.

      Affiliations

    • Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
    • ,
  • Yuan Ji, M.D.

      Affiliations

    • Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China
    • ,
  • Zhao-Chong Zeng, M.D.

      Affiliations

    • Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
    • Corresponding Author InformationReprint requests to: Zhao-Chong Zeng, MD, Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. Tel: 86-21-64041990; Fax: 86-21-64038472
    • ,
  • Zhao-You Tang, M.D.

      Affiliations

    • Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
    • ,
  • Jia Fan, M.D.

      Affiliations

    • Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
    • ,
  • Jian Zhou, M.D.

      Affiliations

    • Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
    • ,
  • Meng-Su Zeng, M.D.

      Affiliations

    • Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China
    • ,
  • Ai-Hong Bi, M.D.

      Affiliations

    • Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China
    • ,
  • Yun-Shan Tan, M.D.

      Affiliations

    • Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China

Received 7 December 2008 ,Revised 29 January 2009 ,Accepted 29 January 2009.

References 

  1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745–750
  2. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. Cancer. 2004;101:3–27
  3. Rosu MR, Dawson LA, Balter JM, et al. Alterations in normal liver doses due to organ motion. Int J Radiation Oncology Biol Phys. 2003;57:1472–1479
  4. Liang SX, Zhu XD, Xu ZY, et al. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiation Oncology Biol Phys. 2006;65:426–434
  5. Kim TH, Kim DY, Park JW, et al. Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable. Am J Clin Oncol. 2006;29:568–575
  6. Hsu WC, Chan SC, Ting LL, et al. Results of three-dimensional conformal radiotherapy and Thalidomide for advanced hepatocellular carcinoma. Jpn Clin Oncol. 2006;36:93–99
  7. American Joint Committee on Cancer: Liver (including intrahepatic bile ducts). AJCC cancer staging manual. In: 6th ed.. New York: Springer-Verlag; 2002;131–138
  8. Cormier JN, Thomas KT, Chari RS, et al. Management of hepatocellular carcinoma. J Gastrointest Surg. 2006;10:761–780
  9. Zeng ZC, Tang ZY, Fan J, et al. A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma. Cancer J. 2004;10:307–316
  10. Dawson LA. The evolving role of radiation therapy in hepatocellular carcinoma. Cancer Radiother. 2008;12:96–101
  11. Kelsey CR, Schefter T, Nash R, et al. Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: Implications for stereotactic body radiotherapy. Am J Clin Oncol. 2005;28:576–580
  12. Kanematsu M, Hoshi H, Yamada T, et al. Overestimating the size of hepatic malignancy on helical CT during arterial portography: Equilibrium phase CT and pathology. J Comput Assist Tomogr. 1997;21:713–719
  13. Irani J, Humbert M, Lecocq B, et al. Renal tumor size: Comparison between computed tomography and surgical measurements. Eur Urol. 2001;39:300–303
  14. Iguchi T, Aishima S, Taketomi A, et al. Extracapsular penetration is a new prognostic factor in human hepatocellular carcinoma. Am J Surg Pathol. 2008;32:1675–1682
  15. Kubo S, Tanaka H, Shuto T, et al. Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B. Surg Today. 2005;35:216–222
  16. Nouso K, Matsumoto E, Kobayashi Y, et al. Risk factors for local and distant recurrence of hepatocellular carcinoma after local ablation therapies. J Gastroenterol Hepatol. 2008;23:453–458
  17. Zeng ZC, Fan Jia, Tang ZY, et al. Prognostic factors for hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving radiotherapy. Cancer Sci. 2008;99:2510–2517
  18. Reichman TW, Bahramipour P, Barone A, et al. Hepatitis status, Child-Pugh classification, and serum AFP levels predict survival in patients treated with transarterial embolization for unresectable HCC. J Gastrointest Surg. 2005;9:638–645
  19. O'Suilleabhain CB, Poon RT, Yong JL, Ooi GC, Tso WK, Fan ST. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg. 2003;90:325–331
  20. Sumie S, Kuromatsu R, Okuda K, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol. 2008;15:1375–1382
  21. Carr BI, Buch SC, Kondragunta V, Pancoska P, Branch RA. Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: A case cohort study. J Gastroenterol Hepatol. 2008;23:1259–1266
  22. Kitai S, Kudo M, Minami Y, et al. A new prognostic staging system for hepatocellular carcinoma: Value of the biomarker combined Japan integrated staging score. Intervirology. 2008;51:86–94
  23. Changchien CS, Chen CL, Yen YH, et al. Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: Prognostic features, treatment outcome, and survival. J Gastroenterol. 2008;43:159–170
  24. Sumie S, Kuromatsu R, Okuda K, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol. 2008;15:1375–1382
  25. Nakagawara H, Ogawa M, Matsumoto N, et al. Evaluation of malignancy of hepatocellular carcinoma using the ultrasonic B-mode method: Clinical significance of extracapsular invasion of hepatocellular carcinoma using ultrasonography. J Med Ultrasonics. 2007;34:83–91
  26. Ishizaki M, Ashida K, Higashi T, et al. The formation of capsule and septum in human hepatocellular carcinoma. Virchows Arch. 2001;438:574–580
  27. Iguchi T, Aishima S, Taketomi A, et al. Extracapsular penetration is a new prognostic factor in human hepatocellular carcinoma. Am J Surg Pathol. 2008;32:1675–1682
  28. Ng IO, Lai ECS, Ng MMT, Fan ST. Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer. 1991;70:45–49
  29. Ishizaki M, Ashida K, Higashi T, et al. The formation of capsule and septum in human hepatocellular carcinoma. Virchows Arch. 2001;438:574–580
  30. Iguchi T, Aishima S, Taketomi A, et al. Extracapsular penetration is a new prognostic factor in human hepatocellular carcinoma. Am J Surg Pathol. 2008;32:1675–1682
  31. Grazioli L, Olivetti L, Fugazzola C, et al. The pseudocapsule in hepatocellular carcinoma: Correlation between dynamic MR imaging and pathology. Eur Radiol. 1999;9:62–67

 Conflict of interest: none.

PII: S0360-3016(09)00218-1

doi: 10.1016/j.ijrobp.2009.01.057

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 2 , Pages 467-476 , 1 February 2010

Article Tools

* Image Usage & Resolution